CELLINK achieves roughly 82% margins on its bioprinters
Erik Gatenholm · He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241 · Apr 18, 2016 · at 15:11
Erik Gatenholm, co-founder of CELLINK, discusses the unit economics and manufacturing margins of their 3D bioprinter hardware.
0:00 / 0:03exact quote · 3.4s
720p mp4 · rendered on demand · StarZero watermark
“We have about 82% margins on them.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Erik Gatenholm
CELLINK projects $4 million in total revenue for 2016
“Total 20 16 revenue, we're going to come up to approximately four four million dollars.”
Gatenholm: Swedish Series A rounds can be as small as $500,000
“A Swedish round a could be basically 500,000 dollars.”
Biotech startups scale through boards of Key Opinion Leaders
“And the KOLs is key opinion leaders. It's kind of a board and special board that you establish of key surgeons and doctors in your field. We're interested in implanting this into animals or into humans. So these are basically your go-to customers that you want…”